profit from every $100 of sales.
$0$100
FACT II Acquisition
$10.80+0.00% today
+4.4% in 1 year
1-year low $10.331-year high $10.81
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
You pay $52.35 for every $1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
FACT II Acquisition vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| FACT II Acquisition | 52.4× · No profit yet | ||
 Churchill Capital Corp X | No profit yet | ||
 Drugs Made In America Acquisition II | 155.8× · No profit yet | ||
 Bain Capital GSS Investment Cor | No profit yet | ||
 Cantor Equity Partners IV | 96.3× · No profit yet |
AI analysis
An AI analyst reads FACT II Acquisition's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2025 |
|---|---|
| 0 | |
| – | |
| -2 | |
| -2 | |
| 5 | |
| 0.21 | |
| – | |
| – | |
| – |
Balance sheet
| In millions of USD | 2025 |
|---|---|
| Total assets | 184 |
| Cash | 1 |
| Total debt | – |
| Total liabilities | 9 |
| 175 | |
| 24 | |
| -1.0% | |
| 2.9% |
Cash flow
| In millions of USD | 2025 |
|---|---|
| -1 | |
| – | |
| -1 | |
| Dividends paid | – |
| – | |
| – |
Valuation
- 52.4×
- –
- 6.72
- 1.1×
- –
- –
- –
- -0.3%
- 1.9%
- 0.0%
Profitability
- 0.0%
- 0.0%
- 0.0%
- 0.0%
- -1.3%
- 358.9%
- 2.6%
- 2.5%
- -1.3%
- –
Growth
- –
- +7.8%
- +98.3%
- –
- −7.6%
Financial health
- -0.3×
- 0.00
- 0.0%
- –
- 3.47
- 3.47
- 0.00
How it ranks in Financial Services
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 7%of 852
Bottom 7%of 733
Bottom 7%of 863
Bottom 17%of 920
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 11, 2026 | 0.06 | – | – |
| Jan 5, 2026 | 0.03 | – | – |
| Mar 31, 2023 | 0.04 | – | – |
| Dec 31, 2022 | 0.03 | – | – |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
25No pass
Benjamin Graham
52No pass
Philip Fisher
31No pass
Peter Lynch
25No pass
Joel Greenblatt
6No pass
Charlie Munger
40No pass
Terry Smith
31No pass
Questions about FACT II Acquisition
Is FACT II Acquisition a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the FACT II Acquisition AI analysis
What does FACT II Acquisition do?
Freedom Acquisition I Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses. It is in Shell Companies.
Does FACT II Acquisition pay a dividend?
No. FACT II Acquisition does not pay a dividend at the moment.
Is FACT II Acquisition stock halal?
Questionable. FACT II Acquisition sits in a grey zone: scholars disagree about its industry. How we check
How has FACT II Acquisition stock done over the past year?
Up 4.4% over the past twelve months, to $10.80. It traded between $10.33 and $10.81, close to its high.
Who are FACT II Acquisition's competitors?
The largest listed companies in the same industry are Churchill Capital Corp X, Drugs Made In America Acquisition II, Bain Capital GSS Investment Cor and Cantor Equity Partners IV. The peers table on this page compares their profit, growth and price with FACT II Acquisition's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.